Up to 50% of patients in cohorts described herein have elevated levels of three main autoantibodies: ANA, AHA, and anti-ssDNA, whereas other autoantibodies are observed at frequencies below 10%. The gene discussed is BTG3; the disease is autoimmune hemolytic anemia.